Price Chart

Headline
Wire
Time (ET)
No data available
DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
             
             
             
             
             
             
             
             

Earnings

Next Report Date --
EPS Estimate Upgrade
Last Actual EPS Upgrade
 
4.00
2.00
1.00
 
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
No data available
Last Report Date --
Beat/Miss Upgrade
Return Since --
Last FQE 09/30/2021
Next FQE 12/30/2021

Profile

Edit
Easton Pharmaceuticals Inc is a diversified specialty pharmaceutical company. It owns and develops proprietary transdermal delivery technology and therapeutic over the counter products and drugs to treat cancer and other diseases. The company also owns exclusive distribution rights in Mexico and Latin America for patented women's diagnostic and preventative care products. It is focused on the development of product Viorra. The firm's products include Nauseasol, Skin Renou HA, Kenestrin gel, and XILIVE, among others.
URL http://www.eastonpharmaceuticalsinc.com
Investor Relations URL N/A
HQ State/Province Ontario
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Equity Style Small Cap/Blend
Next Earnings Release N/A
Last Earnings Release N/A
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0.00%
Forward Yield --
Payout Ratio --
Cash Payout Ratio --
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
-71.97%
686.5%
3.09%
-71.33%
-88.37%
-40.00%
-66.67%
-50.00%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-10.39%
-32.14%
-14.98%
115.7%
50.55%
197.1%
-31.74%
65.37%
-65.02%
-44.04%
-68.72%
-60.09%
-83.95%
-24.91%
3.66%
32.47%
-64.48%
110.0%
93.75%
445.2%
-44.97%
-58.87%
-34.82%
-46.12%
-31.27%
47.27%
-31.65%
-37.82%
-81.28%
-95.69%
-49.88%
-74.05%
-50.48%
As of August 19, 2022.

Fundamentals

2017
2018
2019
2020
2021
No data available
 
4.00
2.00
1.00
 
2017
2018
2019
2020
2021
No data available
 
4.00
2.00
1.00
 

Profile

Edit
Easton Pharmaceuticals Inc is a diversified specialty pharmaceutical company. It owns and develops proprietary transdermal delivery technology and therapeutic over the counter products and drugs to treat cancer and other diseases. The company also owns exclusive distribution rights in Mexico and Latin America for patented women's diagnostic and preventative care products. It is focused on the development of product Viorra. The firm's products include Nauseasol, Skin Renou HA, Kenestrin gel, and XILIVE, among others.
URL http://www.eastonpharmaceuticalsinc.com
Investor Relations URL N/A
HQ State/Province Ontario
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Equity Style Small Cap/Blend
Next Earnings Release N/A
Last Earnings Release N/A
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

No data available
Symbol Dollars Invested % Weight
     
     
     
     
     
     
     
     
     
     

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter EAPH Tweets